Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | STAT6 | P42226 | 1/20 | 0.30 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.30 |
| ▸ | SMAD2 | Q15796 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14565294 | 1.00 | ALOX15 (0.44) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL24459467 | 1.00 | ALOX15 (0.44) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL20610506 | 0.85 | ALOX15 (0.41) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL20610516 | 0.84 | ALOX15 (0.49) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL1844934 | 0.84 | ALOX15 (0.49) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL3926989 | 0.84 | ALOX15 (0.35) | ALOX15ALDH1A1CYP3A4TDP1 | |
| SCHEMBL8656171 | 0.83 | ALOX15 (0.47) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL756421 | 0.82 | ALOX15 (0.47) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL19744738 | 0.82 | ALOX15 (0.47) | ALOX15ALDH1A1CYP3A4TDP1KDM4E | |
| SCHEMBL7925513 | 0.82 | ALOX15 (0.41) | ALOX15ALDH1A1CYP3A4TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| WO-2025120108-A1 | ISOMERIZATION PROCESS | FIRMENICH SA (CH) | 2025-06-12 | — | — | WO | claimed |
| EP-4555060-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | The Procter & Gamble Company (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2024011345-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2024-01-18 | — | — | WO | claimed |
| US-20240010954-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY | 2024-01-11 | — | — | US | claimed |
| EP-4106718-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2022-12-28 | — | — | EP | claimed |
| US-20220142158-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2022-05-12 | — | — | US | claimed |
| EP-3990596-A2 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-05-04 | — | — | EP | claimed |
| CN-113905612-A | Arthropod control composition | 弗门尼舍有限公司 | 2022-01-07 | — | — | CN | claimed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | claimed |
| EP-2087089-A2 | BENEFIT AGENT-CONTAINING DELIVERY PARTICLE | The Procter and Gamble Company (US) | 2009-08-12 | — | — | EP | claimed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | claimed |
| WO-2008153882-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | APPLETON PAPERS INC. (US) | 2008-12-18 | — | — | WO | claimed |
| WO-2008152543-A1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-18 | — | — | WO | claimed |
| WO-2008066773-A2 | BENEFIT AGENT- CONTAINING DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2008-06-05 | — | — | WO | claimed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | claimed |
| WO-2003071425-A2 | PROCESS FOR THE PREPARATION OF 1-(2,6,6-TRIMETHYL-2-CYCLOHEXENE-1-YL)-BUT-2-ENE-1-ONE | VEMULKAR, NAGARAJ, NARAYANSWAMY (IN) | 2003-08-28 | — | — | WO | claimed |
| WO-1990003113-A1 | ATTRACTANCE FOR DACUS LATIFRONS, THE MALAYSIAN FRUIT FLY | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1990-04-05 | — | — | WO | claimed |
| US-4877607-A | CYCLOHEXYL AND CYCLOHEXENYL ALIPHATIC ALCOHOLS AND KETONES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1989-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090311403-A1 | Method of Using Organic Compounds | MGLL, GK, LIPC | ALOX15 448/4885ALDH1A1 788/4885CYP3A4 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.